Your search returned the following 4 documents:

4. Estimating cancer survival and clinical outcome based on genetic tumor progression scores
   Jörg Rahnenführer, Niko Beerenwinkel, Wolfgang A. Schulz, Christian Hartmann, Andreas von Deimling, Bernd Wullich, and Thomas Lengauer
   Bioinformatics 21 (10): 2438-2446, 2005
   
3. Patients with high grade gliomas harboring delections of chromosomes 9p and 10q benefit from temozolomide treatment
   Silke Wemmert, Ralf Ketter, Jörg Rahnenführer, Niko Beerenwinkel, Martin Strowitzki, Wolfgang Feiden, Christian Hartmann, Thomas Lengauer, Florian Stockhammer, Klaus D. Zang, Eckart Meese, Wolf-Ingo Steudel, Andreas von Deimling, and Steffi Urbschat
   Neoplasia 7 (10): 883-893, 2005
   
   
2. Synthesis and Evaluation of Imidazolylmethylenetetrahydronaphthalenes and Imidazolylmethyleneindanes: Potent Inhibitors of Aldosterone Synthase
   Sarah Ulmschneider, Ursula Mueller-Vieira, Markus Mitrenga, Rolf W. Hartmann, S Oberwinkler-Marchais, Christian D. Klein, M. Bureik, R. Bernhardt, Iris Antes, and Thomas Lengauer
   Journal of Medicinal Chemistry 48 (6): 1796-1805, 2005
   
1. Synthesis and Evaluation of Pyridylmethylene-tetrahydronaphthalenes and -indanes: Potent and Selective Inhibitors of Aldosterone Synthase (CYP11B2)
   Sarah Ulmschneider, Ursula Mueller-Vieira, Christian D. Klein, Iris Antes, Thomas Lengauer, and Rolf W. Hartmann
   Journal of Medicinal Chemistry 48 (13): 4489-4490, 2005